Company intelligence / Profile preview

Arcede Pharma

Lund, Skåne län / Skåne County, Swedenarcedepharma.com ↗

Ownership: Private
Employees: ~1
Development stage: Preclinical

Overview

Arcede Pharma developed preclinical drug candidates for COPD and severe asthma, with its lead candidate RCD405 showing promising bronchodilating effects in animal and human airway tissue. The company did not secure financing to advance to clinical trials and is now heading towards voluntary liquidation.

Therapeutic areas: Pulmonology
Modalities: Small moleculeInhalation therapy
Industry: Biotech

Drug pipeline

1 asset

RCD405

Preclinical

Partnerships

Iconovo AB – collaboration on inhaler formulation for RCD405Lund University – academic collaboration on respiratory projects supported by Swelife innovation program.

Beyond the preview

Go deeper on Arcede Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcede Pharma.

Explore the full profile